Novartis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
75,883
Employees75,883
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
75,883
Employees75,883

NVS Key Statistics

Market cap
309.32B
Market cap309.32B
Price-Earnings ratio
19.18
Price-Earnings ratio19.18
Dividend yield
2.31%
Dividend yield2.31%
Average volume
1.65M
Average volume1.65M
High today
$146.35
High today$146.35
Low today
$143.82
Low today$143.82
Open price
$144.56
Open price$144.56
Volume
1.84M
Volume1.84M
52 Week high
$146.35
52 Week high$146.35
52 Week low
$97.39
52 Week low$97.39

NVS News

TipRanks 1d
Novartis enters worldwide license agreement with PepLib

Zonsen PepLib Biotech announced that it has entered into a worldwide license agreement with Novartis (NVS) for an undisclosed peptide-based asset in the field o...

TipRanks 6d
Novartis to add radioligand therapy manufacturing facility in Florida

Novartis (NVS) announced plans to build its fourth U.S. radioligand therapy manufacturing facility in Winter Park, Florida. “The built-for-purpose, state-of-the...

Nasdaq 7d
New Investors: 3 Stocks to Build Your Portfolio Around in 2026

Key Points Novartis, Home Depot, and American Express are well-known, blue chip stocks They have all generated strong gains in recent years and have excellent...

New Investors: 3 Stocks to Build Your Portfolio Around in 2026

Analyst ratings

52%

of 29 ratings
Buy
34.5%
Hold
51.7%
Sell
13.8%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .